303 related articles for article (PubMed ID: 9816888)
1. [Anti-neutrophil cytoplasmic antibodies ANCA in glomerulonephritis and systemic vasculitis with renal involvement--the frequency of occurrence and ability for granulocyte activation in vitro].
Mazanowska O; Klinger M; Wendycz-Domalewska D; Kopeć W
Pol Arch Med Wewn; 1998 May; 99(5):390-7. PubMed ID: 9816888
[TBL] [Abstract][Full Text] [Related]
2. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
[TBL] [Abstract][Full Text] [Related]
3. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.
Jennette JC; Wilkman AS; Falk RJ
Am J Pathol; 1989 Nov; 135(5):921-30. PubMed ID: 2683800
[TBL] [Abstract][Full Text] [Related]
6. Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
Am J Nephrol; 1991; 11(4):318-24. PubMed ID: 1665954
[TBL] [Abstract][Full Text] [Related]
7. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis.
Bygren P; Rasmussen N; Isaksson B; Wieslander J
Eur J Clin Invest; 1992 Dec; 22(12):783-92. PubMed ID: 1478249
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil degranulation in antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis.
Wang F; Chen M; Zhao MH
J Nephrol; 2009; 22(4):491-6. PubMed ID: 19662604
[TBL] [Abstract][Full Text] [Related]
10. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
11. [Serum antineutrophil cytoplasmic antibodies inhibit the ability of granulocytes to kill C. albicans].
Bartůnková J; Fucíková T; Tesar V; Janatková I; Rychlík I; Sulková S
Cas Lek Cesk; 1994 Aug; 133(15):467-70. PubMed ID: 8082112
[TBL] [Abstract][Full Text] [Related]
12. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.
Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H
Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
[TBL] [Abstract][Full Text] [Related]
15. [A novel method for detection of anti-neutrophil cytoplasmic antibody (ANCA) using flow cytometry].
Suzuki Y; Kaneko K; Saionji K
Nihon Jinzo Gakkai Shi; 1995 May; 37(5):71-6. PubMed ID: 7609324
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody (ANCA) and rapidly progressive crescentic glomerulonephritis in Thai population.
Sumethkul V; Changsirikulchai S; Radinahamed P; Chalermsanyakorn P
Asian Pac J Allergy Immunol; 1999 Dec; 17(4):281-7. PubMed ID: 10698468
[TBL] [Abstract][Full Text] [Related]
19. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Heeringa P; Tervaert JW
Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
